[beta2-Microglobulin and carcino-embryonic antigen in bronchogenic carcinoma (author's transl)].
In a series of 52 patients with bronchogenic carcinoma serum levels of beta2-microglobulin (beta2m) and carcino-embryonic antigen (CEA) were studied. No correlation was found between the increase of beta2m (greater than 3,2 mg/l) and CEA (greater than 40 ng/l). High levels were found in 10 % of cases for CEA and in 30% of cases for beta2m. The follow-up of serum levels of beta2m and CEA was studied during the evolution of the disease through monthly assays. Upon 15 cases followed, the same dissociation between beta2m and CEA was observed.
D001609:Beta-Globulins / Q000032:analysis*; D001984:Bronchial Neoplasms / Q000097:blood / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002283:Carcinoma, Bronchogenic / Q000097:blood / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D001613:beta 2-Microglobulin / Q000032:analysis*
D001609:Beta-Globulins; D002272:Carcinoembryonic Antigen; D001613:beta 2-Microglobulin
beta2-Microglobuline et antigène carcino-embryonnaire dans les cancers bronchiques primitifs.